Management of fetal Growth Restriction at term by Angiogenic Factors versus feto-maternal Doppler (GRAFD) to avoid adverse perinatal outcomes: multicenter open-label randomized controlled trial study protocol (Preprint)

MLA

Pablo Garcia-Manau, et al. Management of Fetal Growth Restriction at Term by Angiogenic Factors versus Feto-Maternal Doppler (GRAFD) to Avoid Adverse Perinatal Outcomes: Multicenter Open-Label Randomized Controlled Trial Study Protocol (Preprint). Feb. 2022. EBSCOhost, https://doi.org/10.2196/preprints.37452.

APA

Pablo Garcia-Manau, Manel Mendoza, Erika Bonacina, Raquel Martin-Alonso, Lourdes Martin, Ana Palacios, Maria Luisa Sanchez, Cristina Lesmes, Ivan Hurtado, Esther Perez, Albert Tubau, Patricia Ibañez-Burillo, Marina Alcoz, Nuria Valiño, Elena Moreno, Carlota Borrero, Esperanza Garcia, Eva Lopez-Quesada, Sonia Diaz, … Elena Carreras. (2022). Management of fetal Growth Restriction at term by Angiogenic Factors versus feto-maternal Doppler (GRAFD) to avoid adverse perinatal outcomes: multicenter open-label randomized controlled trial study protocol (Preprint). https://doi.org/10.2196/preprints.37452

Chicago

Pablo Garcia-Manau, Manel Mendoza, Erika Bonacina, Raquel Martin-Alonso, Lourdes Martin, Ana Palacios, Maria Luisa Sanchez, et al. 2022. “Management of Fetal Growth Restriction at Term by Angiogenic Factors versus Feto-Maternal Doppler (GRAFD) to Avoid Adverse Perinatal Outcomes: Multicenter Open-Label Randomized Controlled Trial Study Protocol (Preprint),” February. doi:10.2196/preprints.37452.